Risk Factors for Intracranial Hemorrhage Transformation and Poor Prognosis after Endovascular Treatment for Acute Large Vessel Occlusion Stroke

2.1 Study Objectives

This study collected clinical data of 138 patients with acute large vessel occlusion ischemic stroke who underwent endovascular treatment at the Li Huili Hospital East Campus and Xingning Campus of Ningbo Medical Center from January 1, 2021, to December 31, 2022. Six cases were excluded due to incomplete clinical data, and 132 cases were included in the analysis, including 89 males and 43 females. The age range was 36-92 years (mean age 67.3 ± 12.9 years). Inclusion criteria were: (1) age ≥18 years; (2) clear diagnosis of acute ischemic stroke; (3) confirmation of intracranial large artery occlusion by computed tomographic angiography (CTA), magnetic resonance angiography (MRA), or digital subtraction angiography (DSA); (4) National Institute of Health stroke scale (NIHSS) score ≥6 points; (5) onset time ≤6h, or 6-16h: meeting the DAWN/DEFUSE 3 criteria: low perfusion volume/infarct core>1.8 and maximum infarct core<70ml, or 16-24h: meeting the DAWN criteria: (1) onset 6-24 hours, (2) CT angiography confirmed internal carotid artery intracranial segment and middle cerebral artery M1 segment occlusion, (3) age≥80 years, NIHSS≥10, infarct volume <21ml, or age <80 years, NIHSS≥10, infarct volume <31ml, or age <80 years, NIHSS ≥20, 31ml<infarct volume<51ml; (6) Alberta Stroke Program Early CT Score (ASPECTS) ≥6 points; (7) other patients who did not meet the above criteria but could still benefit from endovascular treatment after comprehensive evaluation. Exclusion criteria were: (1) patients with incomplete clinical and imaging data during the perioperative period; (2) preoperative Modified Rankin Scale (mRs) score ≥3 points. All patients signed an informed consent form for the surgery.

2.2 Treatment methods

If the patient meets the indications for intravenous thrombolysis and there are no contraindications, alteplase is administered for thrombolysis treatment prior to surgery. Endovascular treatment includes catheter aspiration, stent retrieval, balloon angioplasty, and stent implantation. After successful local or general anesthesia (local anesthesia before intra-arterial therapy with remifentanil 20ml/h sedation; general anesthesia after intra-arterial therapy), an 8F guiding catheter is inserted into the proximal part of the lesion site in the internal carotid artery, middle cerebral artery, or vertebral artery through a 0.035-inch guide wire. The guide wire is removed, and a 0.014-inch micro-guide wire and microcatheter are inserted along the guiding catheter to the vascular lesion site, and carefully passed through the lesion site to the distal normal vessel. The micro-guide wire is removed, and an angiography is performed from the microcatheter to confirm that it is located in the vascular lumen and the distal blood vessel is unobstructed. The retrieval stent is sent to the vascular lesion site through the microcatheter and released, and the retrieval stent and thrombus are intertwined. The middle catheter is delivered to the proximal end of the retrieval stent and ensures that the middle catheter passes important vascular branches. The retrieval stent is withdrawn while the middle catheter is aspirated with a 30 ml empty syringe, and the stent and thrombus are removed. In addition to using a retrieval stent in combination with a middle catheter for retrieval, a thrombus can also be directly aspirated with a suction catheter depending on the vascular condition. Successful vascular recanalization is defined as achieving a modified Thrombolysis in Cerebral Infarction (mTICI) grade of 2b/3. If the first retrieval fails, the same retrieval steps can be repeated up to five times. If the post-retrieval angiography reveals severe stenosis of the vascular lesion and the mTICI grade cannot reach 2b/3, balloon angioplasty alone or in combination with intracranial arterial stent implantation may be performed, and antiplatelet therapy with clopidogrel is maintained during the surgery.

2.3 Imaging test

Imaging examinations include head CT, head CTA, head CTP, DSA, etc. The imaging data of all patients were independently reviewed by a senior neurosurgery specialist and a senior radiology specialist. In case of disagreement, a third senior neurosurgery specialist reviewed the images and the differences were resolved through discussion to reach a consensus.

2.4 Data collected

The collected clinical data include: patient age, sex, onset time, underlying diseases (such as hypertension, diabetes, hyperlipidemia, atrial fibrillation, coronary heart disease, history of stroke, etc.), NIHSS score at admission, ASPECTS score, blood pressure, history of anticoagulant treatment, history of antiplatelet treatment, DNT (time from admission to start of intravenous thrombolysis), DPT (time from admission to successful vascular puncture), DRT (time from admission to blood vessel recanalization), blood glucose level at admission, blood routine within 24 hours before and after surgery (including NLR (neutrophil to lymphocyte ratio), hemoglobin level, lymphocyte to platelet ratio), triglycerides, LDL-C, albumin, operation time, intracranial atherosclerotic stenosis, method of thrombus retrieval, postoperative mTICI grading, number of thrombus retrieval attempts, head CT scan within 72 hours after surgery to determine the presence of hemorrhagic transformation. If the presence of intracranial hemorrhage cannot be accurately judged due to interference from contrast agent extravasation, head CT scans may be repeated at 24-hour intervals to assist in the diagnosis. MRS score at discharge and 30 days after discharge. Patients were divided into hemorrhagic and non-hemorrhagic groups based on CT scan results.

2.5 Statistical analysis

The collected data were analyzed using SPSS 26.0 statistical software. Continuous variables were expressed as means ± standard deviation , and the t-test was used for inter-group comparisons. Categorical variables were presented as numbers or percentages. Variables with P < 0.1 in univariate analysis were included in the multivariate logistic regression model to evaluate their independent predictive ability for hemorrhagic transformation after EVT. The data from the logistic regression analysis were presented as odds ratios (OR) and their corresponding 95% confidence intervals. The predictive value was assessed using receiver operating characteristic (ROC) curve analysis. A P value of < 0.05 was considered statistically significant.

3.1 Clinical data analysis

This study included 132 cases of acute large-vessel occlusion ischemic stroke treated with endovascular therapy (EVT) at the Ningbo Medical Center Lihuili Hospital East Campus and Xingning Campus from January 1, 2021, to December 31, 2022. Among them, 30 cases were diagnosed with hemorrhagic transformation within 72 hours after surgery, and 102 cases did not have hemorrhagic transformation. In the hemorrhagic transformation group, 3 cases underwent simple catheter aspiration, 16 cases underwent stent retrieval, and 11 cases underwent catheter aspiration combined with stent retrieval. In the non-hemorrhagic transformation group, 23 cases underwent simple catheter aspiration, 52 cases underwent stent retrieval, and 27 cases underwent catheter aspiration combined with stent retrieval. Vessel recanalization was achieved in 121 cases (91.7%) with mTICI grading of 2b or above, and in 11 cases (8.3%) with mTICI grading below 2b. At discharge, 42 patients (31.2%) had an MRS score of ≤2 (10% in the hemorrhagic transformation group and 38.2% in the non-hemorrhagic transformation group), while 90 patients had an MRS score of >2. At 30 days after discharge, 55 patients (41.7%) had an MRS score of ≤2 (23.3% in the hemorrhagic transformation group and 47.1% in the non-hemorrhagic transformation group), while 77 patients had an MRS score of >2. During hospitalization, 8 patients died (23.3% in the hemorrhagic transformation group and 1% in the non-hemorrhagic transformation group), and 8 patients died within 30 days after discharge (4 in the hemorrhagic transformation group and 4 in the non-hemorrhagic transformation group). A total of 16 patients died within 30 days after EVT (11 in the hemorrhagic transformation group and 5 in the non-hemorrhagic transformation group), with an overall mortality rate of 12.1%. Clinical data collected included patient age, sex, time of onset, comorbidities (such as hypertension, diabetes, hyperlipidemia, atrial fibrillation, coronary heart disease, history of stroke, etc.), NIHSS score at admission, ASPECTS score, blood pressure, previous anticoagulation treatment, previous antiplatelet treatment, DNT (time from admission to start of intravenous thrombolysis), DPT (time from admission to successful puncture of blood vessels), DRT (time from admission to vessel recanalization), blood glucose level at admission, blood routine test (including NLR, hemoglobin level, lymphocyte-to-platelet ratio) within 24 hours before surgery and within 24 hours after surgery, triglycerides, LDL-C(Low-density lipoprotein cholesterol), albumin, surgical time, intracranial arterial stenosis, retrieval method, mTICI grade after surgery, number of retrieval attempts, and CT scan within 72 hours after surgery to assess the presence of hemorrhagic transformation. Statistical analysis was performed using SPSS 26.0, and quantitative data were expressed as mean ± standard deviation . The t-test was used for inter-group comparisons, and parameters with P<0.1 in univariate analysis were included in the multivariate logistic regression model to evaluate their independent predictive ability for hemorrhagic transformation after EVT. The results of the logistic regression analysis were expressed as odds ratios (ORs) and their 95% confidence intervals. The predictive diagnostic value was analyzed by receiver operating characteristic (ROC)

3.2 Logistic regression analysis of hemorrhagic transformation after endovascular treatment for acute large vessel occlusion stroke

A comparison between the bleeding and non-bleeding groups revealed statistically significant differences in NLR (OR=1.105, 95% CI=1.036-1.179, P=0.003) and ASPECTS scores (OR=0.784, 95% CI=0.640-0.962, P=0.0194) within 24 hours after surgery, with P<0.05. Detailed baseline and clinical characteristics are organized in Table 1.

3.3 ROC curve for NLR within 24 hours after EVT in cases with hemorrhagic transformation(Figures1)

• Download figure
• Open in new tab

Figure 1.

AUC=79.1%,P<0.01,95%CI=0.705-0.877,the optimal cutoff value was 0.551, with a sensitivity of 76.7% and a specificity of 78.4%.

3.4 Logistic regression analysis for poor prognosis (MRS score > 2) at discharge

The comparison between the bleeding and non-bleeding groups showed that there were statistically significant differences (P<0.05) in age (OR=1.069, 95%CI=1.011-1.131, P=0.020), history of hypertension (OR=0.335, 95%CI=0.114-0.981, P=0.046), and NIHSS score (OR=1.106, 95%CI=1.010-1.211, P=0.029). Detailed baseline and clinical characteristics are organized in Table 2.